Answers are grounded in this paper and cite their sources.
We address methodological considerations in evaluating risk-reducing mastectomy among young BRCA carriers with prior history of breast cancer, emphasizing time-dependent analysis, realistic assumptions on mortality and contralateral breast cancer risk, and appropriate confounder adjustment as ways to improve accuracy in survival outcome estimates.
No takes yet. Share an insight, caveat, or question.
Delucchi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: